kevin niswender Archives
Research network yields significant findings related to obesity
Feb. 16, 2023— by Jill Clendening In 2017, Vanderbilt University Medical Center was selected to be one of four U.S. medical centers in a Strategically Focused Research Network (SFRN) on Obesity funded by a four-year, $15 million award from the American Heart Association to study obesity and train future obesity-focused investigators. Now, the findings of the research...
Clinical trial at VUMC tests novel treatment for asthma
Nov. 10, 2022—VUMC has begun enrolling patients with asthma in a clinical trial of a novel treatment: a medication approved to treat diabetes and obesity.
Diabetes prevention program run by students shows success
Apr. 21, 2022—Seventy-five percent of participants in a diabetes prevention program run by medical students lost at least 5% of their body weight, and many participants also reported less pain and an overall improved quality of life.
Coronavirus ‘crusaders’ spur VUMC research achievements
Dec. 16, 2020—The development of the vaccines, monoclonal antibodies and antiviral drugs that ultimately will defeat COVID-19 wouldn’t have been possible had it not been for the unflagging and selfless efforts of a global army of research nurses, laboratory personnel, recruiters and other staff.
New core to support investigations into metabolic disorders
Jan. 24, 2019—For several years Vanderbilt University Medical Center researchers have been studying adipose tissue to help unlock the mysteries behind metabolic disorders related to obesity, cardiovascular disease, diabetes and other health conditions, and now they have a new resource to support their investigations.
Clinical Research Center moves to new Round Wing location
Dec. 6, 2018—The new Round Wing location of Vanderbilt University Medical Center’s Elliot V. Newman Clinical Research Center (CRC) opened Dec. 4 with a ribbon-cutting and reception.
Team explores diabetes drug’s ability to treat RSV infection
Jul. 12, 2018—A drug used to treat diabetes may point to new therapies for respiratory syncytial virus (RSV) bronchiolitis — inflammation and obstruction of the lungs’ small airways. A multi-disciplinary team of Vanderbilt investigators has demonstrated that liraglutide reduces the inflammatory response to RSV infection in a mouse model of the disease.
Niswender named Clinical Research Center director
Nov. 30, 2017—Kevin Niswender, MD, PhD, whose work has helped advance understanding of the neural underpinnings of obesity and metabolic syndrome, has been named director of the Clinical Research Center (CRC) at Vanderbilt University Medical Center (VUMC).
VUMC joins cutting-edge obesity research network
Mar. 16, 2017—Vanderbilt University Medical Center (VUMC) is one of four centers receiving a $15 million, four-year research award from the American Heart Association (AHA) to provide cutting-edge research on obesity as part of its sixth Strategically Focused Research Network (SFRN).
Study to track diabetes drug’s ability to also treat asthma
Jan. 19, 2017—Investigators in the Division of Allergy, Pulmonary, and Critical Care Medicine and the Division of Diabetes, Endocrinology, and Metabolism recently received a $1.25 million grant from the National Institute of Allergy and Infectious Diseases.
Award recognizes Niswender’s research achievements
Jan. 28, 2016—Kevin Niswender, M.D., Ph.D., a physician-scientist at Vanderbilt University Medical Center whose work has helped advance understanding of diseases ranging from obesity to schizophrenia, is one of 10 recipients of the 2016 Harrington Scholar-Innovator Awards.
Study shows brain function differs in obese children
Jan. 21, 2016—The brains of children who are obese function differently from those of children of healthy weight, and exhibit an “imbalance” between food-seeking and food-avoiding behaviors, researchers at Vanderbilt University Medical Center have found.
